Lilly Zyprexa, Symbyax Labeling Strengthened

Update elevates information on weight gain and hyperlipidemia from adverse event precaution to “Warning” status and adds to elevated blood sugar warning.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet